C
Globus Medical, Inc.
GMED
$70.70
$1.021.46%
C
Hold
2/24/2025Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 2/24/2025 due to a noticeable decline in the growth index and volatility index. Earnings per share declined from $0.38 to $0.19.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 2/24/2025 due to a noticeable decline in the growth index and volatility index. Earnings per share declined from $0.38 to $0.19.
C
Hold
2/10/2025Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 2/10/2025 due to a major increase in the total return index, growth index and volatility index. Operating cash flow increased 275.34% from $54.26M to $203.65M, and earnings per share increased from $0.23 to $0.38.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 2/10/2025 due to a major increase in the total return index, growth index and volatility index. Operating cash flow increased 275.34% from $54.26M to $203.65M, and earnings per share increased from $0.23 to $0.38.
C
Hold
5/31/2024Upgraded
Globus Medical, Inc. (GMED) was upgraded to C- from D+ on 5/31/2024 due to an increase in the total return index and volatility index.
Globus Medical, Inc. (GMED) was upgraded to C- from D+ on 5/31/2024 due to an increase in the total return index and volatility index.
D
Sell
5/9/2024Downgrade
Globus Medical, Inc. (GMED) was downgraded to D+ from C- on 5/9/2024 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.1039 to -$0.0526, net income declined 147.34% from $15.03M to -$7.12M, and operating cash flow declined 49.95% from $104.67M to $52.39M.
Globus Medical, Inc. (GMED) was downgraded to D+ from C- on 5/9/2024 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.1039 to -$0.0526, net income declined 147.34% from $15.03M to -$7.12M, and operating cash flow declined 49.95% from $104.67M to $52.39M.
C
Hold
4/26/2024Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 4/26/2024 due to a decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 4/26/2024 due to a decline in the volatility index and total return index.
C
Hold
4/1/2024Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 4/1/2024 due to an increase in the volatility index, valuation index and total return index.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 4/1/2024 due to an increase in the volatility index, valuation index and total return index.
C
Hold
3/14/2024Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 3/14/2024 due to a decline in the volatility index.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 3/14/2024 due to a decline in the volatility index.
C
Hold
2/27/2024Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 2/27/2024 due to a substantial increase in the growth index and volatility index. Earnings per share increased from $0.0088 to $0.1039, operating cash flow increased 107.34% from $50.48M to $104.67M, and total revenue increased 60.71% from $383.64M to $616.53M.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 2/27/2024 due to a substantial increase in the growth index and volatility index. Earnings per share increased from $0.0088 to $0.1039, operating cash flow increased 107.34% from $50.48M to $104.67M, and total revenue increased 60.71% from $383.64M to $616.53M.
C
Hold
10/19/2023Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 10/19/2023 due to a decline in the volatility index, valuation index and total return index.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 10/19/2023 due to a decline in the volatility index, valuation index and total return index.
C
Hold
9/29/2023Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 9/29/2023 due to an increase in the volatility index and valuation index.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 9/29/2023 due to an increase in the volatility index and valuation index.
C
Hold
9/14/2023Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 9/14/2023 due to a substantial decline in the growth index, volatility index and total return index. Operating cash flow declined 34.3% from $53.31M to $35.03M.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 9/14/2023 due to a substantial decline in the growth index, volatility index and total return index. Operating cash flow declined 34.3% from $53.31M to $35.03M.
C
Hold
4/14/2023Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/14/2023 due to a noticeable decline in the total return index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/14/2023 due to a noticeable decline in the total return index.
C
Hold
2/22/2023Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 2/22/2023 due to a large increase in the valuation index, growth index and solvency index. Operating cash flow increased 94.33% from $32.92M to $63.98M, total revenue increased 8.01% from $254.15M to $274.5M, and EBIT increased 4.69% from $59.05M to $61.82M.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 2/22/2023 due to a large increase in the valuation index, growth index and solvency index. Operating cash flow increased 94.33% from $32.92M to $63.98M, total revenue increased 8.01% from $254.15M to $274.5M, and EBIT increased 4.69% from $59.05M to $61.82M.
C
Hold
8/8/2022Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 8/8/2022 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 17.47% from $44.69M to $36.88M, and the quick ratio declined from 4.55 to 4.15.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 8/8/2022 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 17.47% from $44.69M to $36.88M, and the quick ratio declined from 4.55 to 4.15.
C
Hold
8/5/2022Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 8/5/2022 due to an increase in the total return index.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 8/5/2022 due to an increase in the total return index.
C
Hold
7/20/2022Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 7/20/2022 due to a substantial decline in the total return index, volatility index and solvency index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 7/20/2022 due to a substantial decline in the total return index, volatility index and solvency index.
C
Hold
5/3/2022Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 5/3/2022 due to a large increase in the total return index, valuation index and volatility index.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 5/3/2022 due to a large increase in the total return index, valuation index and volatility index.
C
Hold
4/18/2022Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/18/2022 due to a decline in the valuation index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/18/2022 due to a decline in the valuation index.
C
Hold
3/15/2022Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 3/15/2022 due to an increase in the volatility index and total return index.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 3/15/2022 due to an increase in the volatility index and total return index.
C
Hold
2/23/2022Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 2/23/2022 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.45 to $0.1416, net income declined 68% from $47.21M to $15.11M, and EBIT declined 51.95% from $54.3M to $26.09M.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 2/23/2022 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.45 to $0.1416, net income declined 68% from $47.21M to $15.11M, and EBIT declined 51.95% from $54.3M to $26.09M.
C
Hold
2/11/2022Downgrade
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 2/11/2022 due to a decline in the volatility index, total return index and efficiency index.
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 2/11/2022 due to a decline in the volatility index, total return index and efficiency index.
B
Buy
11/3/2021Upgraded
Globus Medical, Inc. (GMED) was upgraded to B- from C on 11/3/2021 due to a significant increase in the growth index, valuation index and volatility index. Total revenue increased 10.41% from $227.34M to $251.02M, and EBIT increased 9.17% from $54.73M to $59.75M.
Globus Medical, Inc. (GMED) was upgraded to B- from C on 11/3/2021 due to a significant increase in the growth index, valuation index and volatility index. Total revenue increased 10.41% from $227.34M to $251.02M, and EBIT increased 9.17% from $54.73M to $59.75M.
C
Hold
10/19/2020Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 10/19/2020 due to an increase in the total return index.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 10/19/2020 due to an increase in the total return index.
C
Hold
10/2/2020Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 10/2/2020 due to a decline in the total return index.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 10/2/2020 due to a decline in the total return index.
C
Hold
9/17/2020Upgraded
Globus Medical, Inc. (GMED) was upgraded to C from C- on 9/17/2020 due to an increase in the total return index, valuation index and volatility index.
Globus Medical, Inc. (GMED) was upgraded to C from C- on 9/17/2020 due to an increase in the total return index, valuation index and volatility index.
C
Hold
9/2/2020Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from C on 9/2/2020 due to a significant decline in the growth index, valuation index and efficiency index. EBIT declined 187.29% from $29M to -$25.31M, earnings per share declined from $0.25 to -$0.2137, and net income declined 180.3% from $25.95M to -$20.84M.
Globus Medical, Inc. (GMED) was downgraded to C- from C on 9/2/2020 due to a significant decline in the growth index, valuation index and efficiency index. EBIT declined 187.29% from $29M to -$25.31M, earnings per share declined from $0.25 to -$0.2137, and net income declined 180.3% from $25.95M to -$20.84M.
C
Hold
4/9/2020Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/9/2020 due to a decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 4/9/2020 due to a decline in the volatility index and total return index.
C
Hold
2/26/2020Downgrade
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 2/26/2020 due to a decline in the growth index, efficiency index and volatility index. Operating cash flow declined 2.79% from $55.87M to $54.31M.
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 2/26/2020 due to a decline in the growth index, efficiency index and volatility index. Operating cash flow declined 2.79% from $55.87M to $54.31M.
B
Buy
11/27/2019Upgraded
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 11/27/2019 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 147.23% from $22.6M to $55.87M, EBIT increased 2.96% from $42.98M to $44.25M, and total revenue increased 0.86% from $194.54M to $196.22M.
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 11/27/2019 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 147.23% from $22.6M to $55.87M, EBIT increased 2.96% from $42.98M to $44.25M, and total revenue increased 0.86% from $194.54M to $196.22M.
C
Hold
9/11/2019Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 9/11/2019 due to an increase in the volatility index and total return index.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 9/11/2019 due to an increase in the volatility index and total return index.
C
Hold
5/22/2019Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 5/22/2019 due to a decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 5/22/2019 due to a decline in the volatility index and total return index.
C
Hold
5/7/2019Downgrade
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 5/7/2019 due to a major decline in the growth index, volatility index and total return index. EBIT declined 23.96% from $49.52M to $37.66M, operating cash flow declined 11.49% from $44.29M to $39.2M, and earnings per share declined from $0.3594 to $0.33.
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 5/7/2019 due to a major decline in the growth index, volatility index and total return index. EBIT declined 23.96% from $49.52M to $37.66M, operating cash flow declined 11.49% from $44.29M to $39.2M, and earnings per share declined from $0.3594 to $0.33.
B
Buy
12/17/2018Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 12/17/2018 due to a significant decline in the total return index.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 12/17/2018 due to a significant decline in the total return index.
B
Buy
12/26/2017Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from B- on 12/26/2017 due to a significant increase in the total return index and growth index. Operating cash flow increased 35.79% from $25.98M to $35.27M, and EBIT increased 1.38% from $38.58M to $39.12M.
Globus Medical, Inc. (GMED) was upgraded to B from B- on 12/26/2017 due to a significant increase in the total return index and growth index. Operating cash flow increased 35.79% from $25.98M to $35.27M, and EBIT increased 1.38% from $38.58M to $39.12M.
B
Buy
10/13/2017Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/13/2017 due to a large decline in the total return index, growth index and efficiency index. Operating cash flow declined 51.4% from $53.45M to $25.98M, EBIT declined 6.81% from $41.4M to $38.58M, and earnings per share declined from $0.2991 to $0.29.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/13/2017 due to a large decline in the total return index, growth index and efficiency index. Operating cash flow declined 51.4% from $53.45M to $25.98M, EBIT declined 6.81% from $41.4M to $38.58M, and earnings per share declined from $0.2991 to $0.29.
B
Buy
6/16/2017Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from B- on 6/16/2017 due to a major increase in the total return index and volatility index.
Globus Medical, Inc. (GMED) was upgraded to B from B- on 6/16/2017 due to a major increase in the total return index and volatility index.
B
Buy
1/18/2017Upgraded
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 1/18/2017 due to a noticeable increase in the volatility index.
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 1/18/2017 due to a noticeable increase in the volatility index.
C
Hold
12/1/2016Upgraded
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 12/1/2016 due to an increase in the volatility index and valuation index.
Globus Medical, Inc. (GMED) was upgraded to C+ from C on 12/1/2016 due to an increase in the volatility index and valuation index.
C
Hold
10/26/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 10/26/2016 due to a noticeable decline in the volatility index and valuation index.
Globus Medical, Inc. (GMED) was downgraded to C from C+ on 10/26/2016 due to a noticeable decline in the volatility index and valuation index.
C
Hold
9/29/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 9/29/2016 due to a decline in the volatility index.
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 9/29/2016 due to a decline in the volatility index.
B
Buy
9/16/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 9/16/2016 due to a decline in the volatility index.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 9/16/2016 due to a decline in the volatility index.
B
Buy
8/1/2016Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from B- on 8/1/2016 due to an increase in the total return index, volatility index and solvency index. The quick ratio increased from 5.45 to 5.9.
Globus Medical, Inc. (GMED) was upgraded to B from B- on 8/1/2016 due to an increase in the total return index, volatility index and solvency index. The quick ratio increased from 5.45 to 5.9.
B
Buy
6/6/2016Upgraded
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 6/6/2016 due to an increase in the volatility index and valuation index.
Globus Medical, Inc. (GMED) was upgraded to B- from C+ on 6/6/2016 due to an increase in the volatility index and valuation index.
C
Hold
4/21/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 4/21/2016 due to a noticeable decline in the total return index and volatility index.
Globus Medical, Inc. (GMED) was downgraded to C+ from B- on 4/21/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy
3/24/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 3/24/2016 due to a noticeable decline in the total return index.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 3/24/2016 due to a noticeable decline in the total return index.
B
Buy
3/11/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to B from A on 3/11/2016 due to a significant decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to B from A on 3/11/2016 due to a significant decline in the volatility index and total return index.
A
Buy
1/26/2016Upgraded
Globus Medical, Inc. (GMED) was upgraded to A from A- on 1/26/2016 due to an increase in the total return index and volatility index.
Globus Medical, Inc. (GMED) was upgraded to A from A- on 1/26/2016 due to an increase in the total return index and volatility index.
A
Buy
1/22/2016Upgraded
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 1/22/2016 due to a large increase in the total return index, volatility index and valuation index.
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 1/22/2016 due to a large increase in the total return index, volatility index and valuation index.
B
Buy
1/7/2016Downgrade
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 1/7/2016 due to a decline in the valuation index.
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 1/7/2016 due to a decline in the valuation index.
A
Buy
12/23/2015Upgraded
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 12/23/2015 due to an increase in the volatility index.
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 12/23/2015 due to an increase in the volatility index.
B
Buy
12/16/2015Upgraded
Globus Medical, Inc. (GMED) was upgraded to B+ from B on 12/16/2015 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 128.3% from $13.16M to $30.05M, earnings per share increased from $0.25 to $0.2783, and EBIT increased 8.82% from $37.4M to $40.7M.
Globus Medical, Inc. (GMED) was upgraded to B+ from B on 12/16/2015 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 128.3% from $13.16M to $30.05M, earnings per share increased from $0.25 to $0.2783, and EBIT increased 8.82% from $37.4M to $40.7M.
B
Buy
11/4/2015Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from B- on 11/4/2015 due to an increase in the volatility index.
Globus Medical, Inc. (GMED) was upgraded to B from B- on 11/4/2015 due to an increase in the volatility index.
B
Buy
10/16/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/16/2015 due to a noticeable decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/16/2015 due to a noticeable decline in the volatility index and total return index.
B
Buy
9/25/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to B from B+ on 9/25/2015 due to a significant decline in the volatility index, growth index and efficiency index. Operating cash flow declined 62.04% from $34.67M to $13.16M, earnings per share declined from $0.26 to $0.25, and EBIT declined 2.98% from $38.55M to $37.4M.
Globus Medical, Inc. (GMED) was downgraded to B from B+ on 9/25/2015 due to a significant decline in the volatility index, growth index and efficiency index. Operating cash flow declined 62.04% from $34.67M to $13.16M, earnings per share declined from $0.26 to $0.25, and EBIT declined 2.98% from $38.55M to $37.4M.
B
Buy
7/23/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 7/23/2015 due to a decline in the valuation index.
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 7/23/2015 due to a decline in the valuation index.
A
Buy
5/6/2015Upgraded
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 5/6/2015 due to a substantial increase in the growth index, volatility index and valuation index. Operating cash flow increased 1,682.52% from $1.95M to $34.67M, and total revenue increased 8.14% from $121.7M to $131.6M.
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 5/6/2015 due to a substantial increase in the growth index, volatility index and valuation index. Operating cash flow increased 1,682.52% from $1.95M to $34.67M, and total revenue increased 8.14% from $121.7M to $131.6M.
B
Buy
2/27/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 2/27/2015 due to a significant decline in the growth index and volatility index. Operating cash flow declined 94.54% from $35.65M to $1.95M.
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 2/27/2015 due to a significant decline in the growth index and volatility index. Operating cash flow declined 94.54% from $35.65M to $1.95M.
A
Buy
2/17/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to A- from A on 2/17/2015 due to a decline in the total return index and valuation index.
Globus Medical, Inc. (GMED) was downgraded to A- from A on 2/17/2015 due to a decline in the total return index and valuation index.
A
Buy
1/16/2015Upgraded
Globus Medical, Inc. (GMED) was upgraded to A from B+ on 1/16/2015 due to an increase in the volatility index and total return index.
Globus Medical, Inc. (GMED) was upgraded to A from B+ on 1/16/2015 due to an increase in the volatility index and total return index.
B
Buy
1/5/2015Downgrade
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 1/5/2015 due to a decline in the volatility index and valuation index.
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 1/5/2015 due to a decline in the volatility index and valuation index.
A
Buy
12/19/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 12/19/2014 due to an increase in the volatility index and total return index.
Globus Medical, Inc. (GMED) was upgraded to A- from B+ on 12/19/2014 due to an increase in the volatility index and total return index.
B
Buy
12/3/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to B+ from B on 12/3/2014 due to a large increase in the growth index, volatility index and efficiency index. Operating cash flow increased 188.62% from $12.35M to $35.65M, net income increased 11.69% from $20.65M to $23.06M, and earnings per share increased from $0.2192 to $0.24.
Globus Medical, Inc. (GMED) was upgraded to B+ from B on 12/3/2014 due to a large increase in the growth index, volatility index and efficiency index. Operating cash flow increased 188.62% from $12.35M to $35.65M, net income increased 11.69% from $20.65M to $23.06M, and earnings per share increased from $0.2192 to $0.24.
B
Buy
10/27/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from B- on 10/27/2014 due to an increase in the volatility index and total return index.
Globus Medical, Inc. (GMED) was upgraded to B from B- on 10/27/2014 due to an increase in the volatility index and total return index.
B
Buy
10/10/2014Downgrade
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/10/2014 due to a large decline in the volatility index, total return index and valuation index.
Globus Medical, Inc. (GMED) was downgraded to B- from B on 10/10/2014 due to a large decline in the volatility index, total return index and valuation index.
B
Buy
9/2/2014Downgrade
Globus Medical, Inc. (GMED) was downgraded to B from B+ on 9/2/2014 due to a noticeable decline in the volatility index and total return index.
Globus Medical, Inc. (GMED) was downgraded to B from B+ on 9/2/2014 due to a noticeable decline in the volatility index and total return index.
B
Buy
8/25/2014Downgrade
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 8/25/2014 due to a decline in the volatility index.
Globus Medical, Inc. (GMED) was downgraded to B+ from A- on 8/25/2014 due to a decline in the volatility index.
A
Buy
8/8/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to A- from B on 8/8/2014 due to a noticeable increase in the valuation index, growth index and efficiency index. Total capital increased 5.23% from $502.07M to $528.31M.
Globus Medical, Inc. (GMED) was upgraded to A- from B on 8/8/2014 due to a noticeable increase in the valuation index, growth index and efficiency index. Total capital increased 5.23% from $502.07M to $528.31M.
B
Buy
7/1/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from C- on 07/01/2014.
Globus Medical, Inc. (GMED) was upgraded to B from C- on 07/01/2014.
C
Hold
6/30/2014Downgrade
Globus Medical, Inc. (GMED) was downgraded to C- from B on 6/30/2014 due to a decline in the total return index, growth index and valuation index. Operating cash flow declined 10.49% from $32.66M to $29.23M, EBIT declined 4.42% from $36.38M to $34.78M, and total revenue declined 0.9% from $115.25M to $114.21M.
Globus Medical, Inc. (GMED) was downgraded to C- from B on 6/30/2014 due to a decline in the total return index, growth index and valuation index. Operating cash flow declined 10.49% from $32.66M to $29.23M, EBIT declined 4.42% from $36.38M to $34.78M, and total revenue declined 0.9% from $115.25M to $114.21M.
B
Buy
2/28/2014Upgraded
Globus Medical, Inc. (GMED) was upgraded to B from D on 2/28/2014 due to a major increase in growth, total return and efficiency. Operating cash flow increased 273.69% from $8.98M to $33.56M, net income increased 173.5% from $7.43M to $20.31M, and earnings per share increased from $0.08 to $0.2183.
Globus Medical, Inc. (GMED) was upgraded to B from D on 2/28/2014 due to a major increase in growth, total return and efficiency. Operating cash flow increased 273.69% from $8.98M to $33.56M, net income increased 173.5% from $7.43M to $20.31M, and earnings per share increased from $0.08 to $0.2183.
NYSE
03/14/2025 12:55PM Eastern
Quotes delayed
